Spinal Modulation has secured $30 million in Series D financing adding a new investor Medtronic. The company’s existing investors include DeNovo Ventures, ePlanet/DFJ, InCube Ventures and Raffles Venture Partners.
The Menlo Park-based medical device start-up intends to use the proceeds to perform clinical trials both in the U.S. and internationally. In addition, the company is seeking to start commercialization outside the U.S.
Click here for the release from Spinal Modulation.